FGF21: The center of a transcriptional nexus in metabolic regulation

Current Diabetes Reviews

Volumn 8, Issue 4, 2012, Pages 285-293

  Adams, A C ^a   Kharitonenkov, A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Expression regulation; FGF21; Metabolism

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ACTIVATING TRANSCRIPTION FACTOR 2; CHOLESTEROL; DACTINOMYCIN; FIBRIC ACID DERIVATIVE; FIBROBLAST GROWTH FACTOR 21; GLUCOCORTICOID RECEPTOR; ISOPRENALINE; MESSENGER RNA; NORADRENALIN; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIOGLITAZONE; RETINOID RELATED ORPHAN RECEPTOR ALPHA; ROSIGLITAZONE; TRANSCRIPTION FACTOR FKHR; TROGLITAZONE; UNCOUPLING PROTEIN 1;

BROWN ADIPOSE TISSUE; CIRCADIAN RHYTHM; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; IN VIVO STUDY; METABOLIC REGULATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSCRIPTION INITIATION;

DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MALE; OBESITY; SIGNAL TRANSDUCTION;

EID: 84862622024     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912800840505     Document Type: Review

References (90)

1. Gupta RK, Rosen ED, Spiegelman BM. Identifying novel transcriptional components controlling energy metabolism. Cell Metab 2011; 14(6): 739-45.
2. Itoh N, Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res 2010; 342(1): 1-11.
3. Kharitonenkov A, Shanafelt AB. Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs 2008; 22(1): 37-44.
4. Kharitonenkov A, Shiyanova TL, Koester A, et al., FGF-21 as a novel metabolic regulator. J Clin Invest 2005; 115(6): 1627-35.
5. Wu X, Ge H, Lemon B, et al. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem 2010; 285(8): 5165-70.
6. Huang X, Yu C, Jin C, et al. Forced expression of hepatocytespecific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis. Mol Carcinog 2006; 45(12): 934-42.
7. Kurosu H, Kuro-o M. The Klotho gene family and the endocrine fibroblast growth factors. Curr Opin Nephrol Hypertens 2008; 17(4): 368-72.
8. Ogawa Y, Kurosu H, Yamamoto M, et al. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci U S A 2007; 104(18): 7432-37.
9. Ito S, Kinoshita S, Shiraishi N, et al. Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein. Mech Dev 2000; 98(1-2): 115-19.
10. Kharitonenkov A. FGFs and metabolism. Curr Opin Pharmacol 2009; 9(6): 805-10.
11. Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 2000; 1492(1): 203-6.
12. Wang H, Qiang L, Farmer SR. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol 2008; 28(1): 188-200.
13. Hondares E, Rosell M, Gonzalez FJ, Giralt M, Iglesias R, Villarroya F. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab 2010; 11(3): 206-12.
14. Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K. FGF21 is an Akt-regulated myokine. FEBS Lett 2008; 582(27): 3805-10.
15. Wente W, Efanov AM, Brenner M, et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 2006; 55(9): 2470-78.
16. Johnson CL, Weston JY, Chadi SA, et al. Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice. Gastroenterology 2009; 137(5): 1795-1804.
17. Kharitonenkov A, Larsen P. FGF21 reloaded: challenges of a rapidly growing field. Trends Endocrinol Metab 2011; 22(3): 81-86.
18. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E, Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007; 5(6): 426-37.
19. Eckert-Boulet N, Regenberg B, Nielsen J. Grr1p is required for transcriptional induction of amino acid permease genes and proper transcriptional regulation of genes in carbon metabolism of Saccharomyces cerevisiae. Curr Genet 2005; 47(3): 139-49.
20. Dasarathy S, Yang Y, McCullough AJ, Marczewski S, Bennett C, Kalhan SC. Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol 2011; 23(5): 382-88.
21. Tyynismaa H, Carroll CJ, Raimundo N, et al. Mitochondrial myopathy induces a starvation-like response. Hum Mol Genet 2010; 19(20): 3948-58.
22. Cahill GF, Jr. Fuel metabolism in starvation. Annu Rev Nutr 2006; 26: 1-22.
23. Felig P, Owen OE, Wahren J, Cahill GF, Jr. Amino acid metabolism during prolonged starvation. J Clin Invest 1969; 48(3): 584-94.
24. Sokolovic M, Sokolovic A, van Roomen CP, et al. Unexpected effects of fasting on murine lipid homeostasis--transcriptomic and lipid profiling. J Hepatol 2010; 52(5): 737-44.
25. Sokolovic M, Sokolovic A, Wehkamp D, et al., The transcriptomic signature of fasting murine liver. BMC Genomics 2008; 9: 528.
26. Hakvoort TB, Moerland PD, Frijters R, et al., Interorgan coordination of the murine adaptive response to fasting. J Biol Chem 2011; 286(18): 16332-343.
27. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS, Defect in peroxisome proliferator-activated receptor alphainducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 2000; 275(37): 28918-28.
28. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007; 5(6): 415-25.
29. Lundasen T, Hunt MC, Nilsson LM, et al. PPARalpha is a key regulator of hepatic FGF21. Biochem Biophys Res Commun 2007; 360(2): 437-40.
30. Galman C, Lundasen T, Kharitonenkov A, et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab 2008; 8(2): 169-74.
31. Dushay J, Chui PC, Gopalakrishnan GS, et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010; 139(2): 456-63.
32. Hojman P, Pedersen M, Nielsen AR, et al. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 2009; 58(12): 2797-801.
33. Moyers JS, Shiyanova TL, Mehrbod F, et al. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J Cell Physiol 2007; 210(1): 1-6.
34. Muise ES, Azzolina B, Kuo DW, et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 2008; 74(2): 403-12.
35. Oishi K, Tomita T. Thiazolidinediones are potent inducers of fibroblast growth factor 21 expression in the liver. Biol Pharm Bull 2011; 34(7): 1120-21.
36. Rial E, Gonzalez-Barroso MM, Fleury C, Bouillaud F. The structure and function of the brown fat uncoupling protein UCP1: current status. Biofactors 1998; 8(3-4): 209-19.
37. Hondares E, Iglesias R, Giralt A, et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem 2011; 286(15): 12983-990.
38. Klingenspor M. Cold-induced recruitment of brown adipose tissue thermogenesis. Exp Physiol 2003; 88(1): 141-48.
39. Scarpace PJ, Tse C, Matheny M. Thermoregulation with age: restoration of beta(3)-adrenergic responsiveness in brown adipose tissue by cold exposure. Proc Soc Exp Biol Med 1996; 211(4): 374-80.
40. Takahashi A, Shimazu T, Maruyama Y. Importance of sympathetic nerves for the stimulatory effect of cold exposure on glucose utilization in brown adipose tissue. Jpn J Physiol 1992; 42(4): 653-64.
41. Chartoumpekis DV, Habeos IG, Ziros PG, Psyrogiannis AI, Kyriazopoulou VE, Papavassiliou AG. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol Med 2011; 17(7-8): 736-40.
42. Estall JL, Ruas JL, Choi CS, et al. PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis. Proc Natl Acad Sci U S A 2009; 106(52): 22510-515.
43. Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell 2008; 134(5): 728-42.
44. Sahar S, Sassone-Corsi P. Regulation of metabolism: the circadian clock dictates the time. Trends Endocrinol Metab 2012; 23(1): 1-8.
45. Lin JD, Liu C, Li S. Integration of energy metabolism and the mammalian clock. Cell Cycle 2008; 7(4): 453-57.
46. Liu C, Li S, Liu T, Borjigin J, Lin JD. Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism. Nature 2007; 447(7143): 477-81.
47. Puigserver P, Adelmant G, Wu Z, et al. Activation of PPARgamma coactivator-1 through transcription factor docking. Science 1999; 286(5443): 1368-71.
48. Lin J, Handschin C, Spiegelman BM, Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005; 1(6): 361-70.
49. Estall JL, Kahn M, Cooper MP, et al. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression. Diabetes 2009; 58(7): 1499-1508.
50. Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413(6852): 131-38.
51. Koo SH, Satoh H, Herzig S, et al. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med 2004; 10(5): 530-34.
52. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000; 20(5): 1868-76.
53. Yin L, Lazar MA. The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol Endocrinol 2005; 19(6): 1452-59.
54. Yin L, Wu N, Curtin JC, et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 2007; 318(5857): 1786-89.
55. Wu N, Yin L, Hanniman EA, Joshi S, Lazar MA, Negative feedback maintenance of heme homeostasis by its receptor, Reverbalpha. Genes Dev 2009; 23(18): 2201-9.
56. Handschin C, Lin J, Rhee J, et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 2005; 122(4): 505-15.
57. Wang Y, Solt LA, Burris TP. Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha. J Biol Chem 2010; 285(21): 15668-673.
58. Oishi K, Konishi M, Murata Y, Itoh N. Time-imposed daily restricted feeding induces rhythmic expression of Fgf21 in white adipose tissue of mice. Biochem Biophys Res Commun 2011; 412(2): 396-400.
59. Oishi K, Uchida D, Ishida N. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. FEBS Lett 2008; 582(25-26): 3639-642.
60. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science 2010; 330: 6009: 1349-54.
61. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005; 308(5724): 1043-1045.
62. Andersen B, Beck-Nielsen H, Hojlund K. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers. Clin Endocrinol (Oxf) 2011; 75(4): 514-19.
63. Leiser SF, Miller RA. Nrf2 signaling, a mechanism for cellular stress resistance in long-lived mice. Mol Cell Biol 2010; 30(3): 871-84.
64. Pi J, Zhang Q, Fu J, et al. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol 2010; 244(1): 77-83.
65. Kang KW, Lee SJ, Kim SG. Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal 2005; 7(11-12): 1664-73.
66. Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 2004; 24(19): 8477-86.
67. Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004; 10(11): 549-57.
68. Nguyen T, Yang CS, Pickett CB. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 2004; 37(4): 433-41.
69. Tanaka Y, Aleksunes LM, Yeager RL, et al. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a highfat diet. J Pharmacol Exp Ther 2008; 325(2): 655-64.
70. Yates MS, Tran QT, Dolan PM, et al. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 2009; 30(6): 1024-31.
71. Chartoumpekis DV, Ziros PG, Psyrogiannis AI, et al. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 2011; 60(10): 2465-73.
72. Milder JB, Liang LP, Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol Dis 2010; 40(1): 238-44.
73. Zhang YK, Yeager RL, Tanaka Y, Klaassen CD. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine-and choline-deficient diet. Toxicol Appl Pharmacol 2010; 245(3): 326-34.
74. Yamashita H, Takenoshita M, Sakurai M, et al. A glucoseresponsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 2001; 98(16): 9116-21.
75. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A 2001; 98(24): 13710-715.
76. Iizuka K, Horikawa Y. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J 2008; 55(4): 617-24.
77. Iizuka K, Takeda J, Horikawa Y. Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Lett 2009; 583(17): 2882-86.
78. Sanchez J, Palou A, Pico C. Response to carbohydrate and fat refeeding in the expression of genes involved in nutrient partitioning and metabolism: striking effects on fibroblast growth factor-21 induction. Endocrinology 2009; 150(12): 5341-50.
79. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003; 9(2): 213-19.
80. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93(5): 693-704.
81. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294(5548): 1866-70.
82. Angelovici R, Fait A, Zhu X, et al. Deciphering transcriptional and metabolic networks associated with lysine metabolism during Arabidopsis seed development. Plant Physiol 2009; 151(4): 2058-72.
83. Kalaany NY, Gauthier KC, Zavacki AM, et al. LXRs regulate the balance between fat storage and oxidation. Cell Metab 2005; 1(4): 231-44.
84. Schultz JR, Tu H, Luk A, et al. Role of LXRs in control of lipogenesis. Genes Dev 2000; 14(22): 2831-38.
85. Fontaine C, Rigamonti E, Nohara A, et al. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ Res 2007; 101(1): 40-49.
86. Uebanso T, Taketani Y, Yamamoto H, et al. Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet. J Nutr Biochem 2011.
87. Barthel TK, Mathern DR, Whitfield GK, et al. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J Steroid Biochem Mol Biol 2007; 103(3-5): 381-88.
88. Popescu IR, Helleboid-Chapman A, Lucas A, et al. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett 2010; 584(13): 2845-51.
89. Zhang Y, Edwards PA. FXR signaling in metabolic disease. FEBS Lett 2008; 582(1): 10-18.
90. Zhang Y, Lee FY, Barrera G, et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A 2006; 103(4): 1006-11.